Invesco Ltd. Has $111 Million Holdings in Chemed Corporation $CHE

Key Points

• Invesco Ltd. sold 1,754 shares of Chemed Corporation, reducing its stake by 1.0% to approximately 180,390 shares, valued at $110,998,000 at the end of the last quarter.
• Chemed Corporation reported quarterly earnings of $4.27 per share, falling short of analysts' expectations of $6.02, with revenues at $618.80 million compared to anticipated $650.60 million.
• The company announced an increase in its quarterly dividend from $0.50 to $0.60 per share, scheduled for payment on August 29th, demonstrating a positive shift in shareholder returns.

Invesco Ltd. lessened its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 1.0% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 180,390 shares of the company's stock after selling 1,754 shares during the quarter. Invesco Ltd. owned 1.23% of Chemed worth $110,998,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CHE. Cerity Partners LLC increased its position in Chemed by 13.0% during the 4th quarter. Cerity Partners LLC now owns 959 shares of the company's stock worth $522,000 after purchasing an additional 110 shares in the last quarter. Advisory Services Network LLC increased its position in Chemed by 13.1% during the 4th quarter. Advisory Services Network LLC now owns 482 shares of the company's stock worth $255,000 after purchasing an additional 56 shares in the last quarter. Sterling Capital Management LLC increased its position in Chemed by 53.6% during the 4th quarter. Sterling Capital Management LLC now owns 822 shares of the company's stock worth $435,000 after purchasing an additional 287 shares in the last quarter. Barclays PLC increased its position in Chemed by 20.2% during the 4th quarter. Barclays PLC now owns 11,778 shares of the company's stock worth $6,240,000 after purchasing an additional 1,983 shares in the last quarter. Finally, PEAK6 LLC acquired a new stake in Chemed during the 4th quarter worth approximately $412,000. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Activity

In related news, EVP Nicholas Michael Westfall sold 10,012 shares of the stock in a transaction on Monday, August 4th. The stock was sold at an average price of $421.91, for a total value of $4,224,162.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director George J. Walsh III purchased 200 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The stock was bought at an average price of $417.10 per share, with a total value of $83,420.00. Following the transaction, the director directly owned 3,523 shares in the company, valued at $1,469,443.30. This trade represents a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 3.29% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Wall Street Zen cut Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Bank of America decreased their price target on Chemed from $708.00 to $650.00 and set a "buy" rating for the company in a report on Monday, June 30th. Royal Bank Of Canada decreased their price target on Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Jefferies Financial Group assumed coverage on Chemed in a report on Friday, July 25th. They issued a "hold" rating and a $500.00 price target for the company. Finally, Oppenheimer decreased their price target on Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $579.75.

Chemed Stock Up 0.4%

NYSE CHE traded up $1.9350 during trading hours on Wednesday, hitting $455.7850. The company had a trading volume of 40,123 shares, compared to its average volume of 137,571. The firm has a market cap of $6.64 billion, a P/E ratio of 23.43, a price-to-earnings-growth ratio of 2.45 and a beta of 0.46. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The business has a fifty day simple moving average of $478.38 and a 200-day simple moving average of $542.88.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). The business had revenue of $618.80 million for the quarter, compared to analyst estimates of $650.60 million. Chemed had a net margin of 11.56% and a return on equity of 25.83%. Chemed's revenue for the quarter was up 3.8% on a year-over-year basis. During the same period last year, the business posted $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Monday, August 11th will be paid a dividend of $0.60 per share. This is an increase from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, August 11th. Chemed's dividend payout ratio (DPR) is 12.34%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.